My NCBISign In
New targets for therapy in breast cancer: Mammalian target of rapamycin (mTOR) antagonists
Hetty Carraway, Manuel Hidalgo
Breast Cancer Res. 2004; 6(5): 219–224. Published online 2004 August 12. doi: 10.1186/bcr927
PMCID:
PMC549184
Abstract Full Text PDF–282K

Is Cited by the Following 12 Articles in this Archive:

Targeting Signal Transduction Pathways in Metastatic Breast Cancer: A Comprehensive Review
Lee S. Rosen, Helen Louise Ashurst, Linnea Chap
Oncologist. 2010 March; 15(3): 216–235. Published online 2010 March 3. doi: 10.1634/theoncologist.2009-0145
PMCID:
PMC3227950
Abstract Full Text PDF–925K
Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications
Sadhna Dhingra, Michelle E Rodriguez, Qi Shen, Xuizhen Duan, Melissa L Stanton, Lei Chen, Rongzhen Zhang, Robert E Brown
Int J Clin Exp Pathol. 2011 February 15; 4(2): 134–146. Published online 2010 January 28.
PMCID:
PMC3037199
Abstract Full Text PDF–23M
Nicotine stimulates PPARβ/δ expression in human lung carcinoma cells through activation of PI3-K/mTOR and suppression of AP-2α
Xiaojuan Sun, Jeffrey D. Ritzenthaler, XiaoRong Zhong, Ying Zheng, Jesse Roman, Shou Wei Han
Cancer Res. Author manuscript; available in PMC 2010 August 15.
Published in final edited form as: Cancer Res. 2009 August 15; 69(16): 6445–6453. Published online 2009 August 4. doi: 10.1158/0008-5472.CAN-09-1001
PMCID:
PMC2745317
Abstract Full Text PDF–1.7M Supplementary Material
Inhibition of mTOR attenuates store-operated Ca2+ entry in cells from endarterectomized tissues of patients with chronic thromboembolic pulmonary hypertension
Aiko Ogawa, Amy L. Firth, Weijuan Yao, Michael M. Madani, Kim M. Kerr, William R. Auger, Stuart W. Jamieson, Patricia A. Thistlethwaite, Jason X.-J. Yuan
Am J Physiol Lung Cell Mol Physiol. 2009 October; 297(4): L666–L676. Published online 2009 July 24. doi: 10.1152/ajplung.90548.2008
PMCID:
PMC2770792
Abstract Full Text
Intracellular parasitism with Toxoplasma gondii stimulates mTOR-dependent host cell growth despite impaired signaling to S6K1 and 4E-BP1
Yubao Wang, Louis M. Weiss, Amos Orlofsky
Cell Microbiol. Author manuscript; available in PMC 2010 June 4.
Published in final edited form as: Cell Microbiol. 2009 June; 11(6): 983–1000. Published online 2009 February 27. doi: 10.1111/j.1462-5822.2009.01305.x
PMCID:
PMC2880858
Abstract Full Text PDF–1.7M
PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas
J M Gozgit, B T Pentecost, S A Marconi, R S J Ricketts-Loriaux, C N Otis, K F Arcaro
Br J Cancer. 2007 September 11; 97(6): 809–817. Published online 2007 August 28. doi: 10.1038/sj.bjc.6603926
PMCID:
PMC2360386
Abstract Full Text PDF–428K Supplementary Material
Pathways to Tamoxifen Resistance
Rebecca B. Riggins, Randy S. Schrecengost, Michael S. Guerrero, Amy H. Bouton
Cancer Lett. Author manuscript; available in PMC 2008 October 18.
Published in final edited form as: Cancer Lett. 2007 October 18; 256(1): 1–24. Published online 2007 May 1. doi: 10.1016/j.canlet.2007.03.016
PMCID:
PMC2533271
Abstract Full Text PDF–1003K
The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention
John P Alao
Mol Cancer. 2007; 6: 24. Published online 2007 April 2. doi: 10.1186/1476-4598-6-24
PMCID:
PMC1851974
Abstract Full Text PDF–541K
The Role of Intracellular Signaling in Insulin-mediated Regulation of Drug Metabolizing Enzyme Gene and Protein Expression
Sang K. Kim, Raymond F. Novak
Pharmacol Ther. Author manuscript; available in PMC 2007 March 16.
Published in final edited form as: Pharmacol Ther. 2007 January; 113(1): 88–120. Published online 2006 November 13. doi: 10.1016/j.pharmthera.2006.07.004
PMCID:
PMC1828071
Abstract Full Text PDF–2.2M
PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer
T Fujita, H Doihara, K Kawasaki, D Takabatake, H Takahashi, K Washio, K Tsukuda, Y Ogasawara, N Shimizu
Br J Cancer. 2006 January 30; 94(2): 247–252. Published online 2006 January 24. doi: 10.1038/sj.bjc.6602926
PMCID:
PMC2361109
Abstract Full Text PDF–200K
Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer
H-J Lin, F-C Hsieh, H Song, J Lin
Br J Cancer. 2005 December 12; 93(12): 1372–1381. Published online 2005 November 15. doi: 10.1038/sj.bjc.6602862
PMCID:
PMC2361529
Abstract Full Text PDF–242K
Determining sensitivity to rapamycin and its analogues in breast cancer patients
Caroline J Witton
Breast Cancer Res. 2005; 7(1): 41–42. Published online 2004 December 17. doi: 10.1186/bcr985
PMCID:
PMC1064119
Full Text PDF–32K
You are here: NCBI > Literature > PubMed Central (PMC)
Write to the Help Desk